A citation-based method for searching scientific literature

Helga Bergholtz, Tonje G Lien, David M Swanson, Arnoldo Frigessi, Maria Grazia Daidone, Jörg Tost, Fredrik Wärnberg, Therese Sørlie. NPJ Breast Cancer 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Takamaru Ashikaga, Donald L Weaver, Barbara J Miller, Lynne M Jalovec, Thomas G Frazier,[...]. Lancet Oncol 2007
628
50

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
Erik von Elm, Douglas G Altman, Matthias Egger, Stuart J Pocock, Peter C Gøtzsche, Jan P Vandenbroucke. Int J Surg 2014
50

The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation.
Richard N Shiffman, Jane Dixon, Cynthia Brandt, Abdelwaheb Essaihi, Allen Hsiao, George Michel, Ryan O'Connell. BMC Med Inform Decis Mak 2005
198
50

Sentinel lymph node biopsy is feasible even after total mastectomy.
Mattia Intra, Paolo Veronesi, Oreste D Gentilini, Giuseppe Trifirò, Anastasio Berrettini, Rafaela Cecilio, Marco Colleoni, Mario Rietjens, Alberto Luini, Giovanni Paganelli,[...]. J Surg Oncol 2007
18
50

Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
Tawakalitu O Oseni, Barbara L Smith, Constance D Lehman, Charmi A Vijapura, Niveditha Pinnamaneni, Manisha Bahl. Ann Surg Oncol 2020
4
50


STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.
Patrick M Bossuyt, Johannes B Reitsma, David E Bruns, Constantine A Gatsonis, Paul P Glasziou, Les Irwig, Jeroen G Lijmer, David Moher, Drummond Rennie, Henrica C W de Vet,[...]. BMJ 2015
50

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
34
50

Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Grace Clarke Hillyer, Ling Chen, Dawn L Hershman. Breast Cancer Res Treat 2016
11
50


Risk of death from breast cancer after treatment for ductal carcinoma in situ.
C Wadsten, H Garmo, I Fredriksson, M Sund, F Wärnberg. Br J Surg 2017
14
50

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.
Brigid K Killelea, Jessica B Long, Weixiong Dang, Sarah S Mougalian, Suzanne B Evans, Cary P Gross, Shi-Yi Wang. Ann Surg Oncol 2018
16
50

DCIS and axillary nodal evaluation: compliance with national guidelines.
Katrina B Mitchell, Heather Lin, Yu Shen, Alfred Colfry, Henry Kuerer, Simona F Shaitelman, Gildy V Babiera, Isabelle Bedrosian. BMC Surg 2017
22
50

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
450
50


Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
39
50

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, I T Rubio, S Zackrisson, E Senkus. Ann Oncol 2019
309
50


Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.
Hiba El Hage Chehade, Hannah Headon, Umar Wazir, Houssam Abtar, Abdul Kasem, Kefah Mokbel. Am J Surg 2017
20
50

A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.
Yaolong Chen, Kehu Yang, Ana Marušic, Amir Qaseem, Joerg J Meerpohl, Signe Flottorp, Elie A Akl, Holger J Schünemann, Edwin S Y Chan, Yngve Falck-Ytter,[...]. Ann Intern Med 2017
180
50

Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
Melissa Pilewskie, Maria Karsten, Julia Radosa, Anne Eaton, Tari A King. Ann Surg Oncol 2016
6
50

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.
Gurdeep S Mannu, Emma J Groen, Zhe Wang, Michael Schaapveld, Esther H Lips, Monica Chung, Ires Joore, Flora E van Leeuwen, Hendrik J Teertstra, Gonneke A O Winter-Warnars,[...]. Breast Cancer Res Treat 2019
11
50

Development of the AGREE II, part 2: assessment of validity of items and tools to support application.
Melissa C Brouwers, Michelle E Kho, George P Browman, Jako S Burgers, Françoise Cluzeau, Gene Feder, Béatrice Fervers, Ian D Graham, Steven E Hanna, Julie Makarski. CMAJ 2010
265
50

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
164
50

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Ling Chen, Dawn L Hershman. JAMA Oncol 2015
15
50

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
46
50

Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
Michael R Harowicz, Ashirbani Saha, Lars J Grimm, P Kelly Marcom, Jeffrey R Marks, E Shelley Hwang, Maciej A Mazurowski. J Magn Reson Imaging 2017
10
50

Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates.
Angelena Crown, Debra G Wechter, Janie W Grumley. Ann Surg Oncol 2015
39
50

Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ.
A Fancellu, R M Turner, J M Dixon, A Pinna, P Cottu, N Houssami. Br J Surg 2015
55
50


Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.
S M Feldman, D N Krag, R K McNally, B B Moor, D L Weaver, P Klein. J Am Coll Surg 1999
122
50


Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision.
F Celebioglu, J Frisell, R Danielsson, L Bergkvist. Eur J Surg Oncol 2007
14
50

Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Carina Strell, Janna Paulsson, Shao-Bo Jin, Nicholas P Tobin, Artur Mezheyeuski, Pernilla Roswall, Ceren Mutgan, Nicholas Mitsios, Hemming Johansson, Sarah Marie Wickberg,[...]. J Natl Cancer Inst 2019
33
50

Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
Michael J Campbell, Frederick Baehner, Tess O'Meara, Ekene Ojukwu, Booyeon Han, Rita Mukhtar, Vickram Tandon, Max Endicott, Zelos Zhu, Jasmine Wong,[...]. Breast Cancer Res Treat 2017
54
50

Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
Hideo Shigematsu, Takayuki Kadoya, Norio Masumoto, Kazuo Matsuura, Akiko Emi, Keiko Kajitani, Ai Amioka, Morihito Okada. Clin Breast Cancer 2014
10
50

The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov. Eur J Cancer 2017
11
50

MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.
F R Miller, S J Santner, L Tait, P J Dawson. J Natl Cancer Inst 2000
211
50

Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action.
Donovan A McGrowder, Fabian G Miller, Chukwuemeka R Nwokocha, Melisa S Anderson, Cameil Wilson-Clarke, Kurt Vaz, Lennox Anderson-Jackson, Jabari Brown. Medicines (Basel) 2020
1
100

Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.).
Ao Shang, Shi-Yu Cao, Xiao-Yu Xu, Ren-You Gan, Guo-Yi Tang, Harold Corke, Vuyo Mavumengwana, Hua-Bin Li. Foods 2019
69
50

The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells.
Catherine H Kaschula, Rosanna Tuveri, Ellen Ngarande, Kevin Dzobo, Christopher Barnett, Daniel A Kusza, Lisa M Graham, Arieh A Katz, Mohamed Suhail Rafudeen, M Iqbal Parker,[...]. BMC Cancer 2019
17
50

Phytochemicals of garlic: Promising candidates for cancer therapy.
Yan Zhang, Xingping Liu, Jun Ruan, Xuan Zhuang, Xinzong Zhang, Zhiming Li. Biomed Pharmacother 2020
11
50

Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress.
Voin Petrovic, Anala Nepal, Camilla Olaisen, Siri Bachke, Jonathan Hira, Caroline K Søgaard, Lisa M Røst, Kristine Misund, Trygve Andreassen, Torun M Melø,[...]. Nutrients 2018
20
50


Tristetraprolin: A novel target of diallyl disulfide that inhibits the progression of breast cancer.
Ting Xiong, Xiao-Wang Liu, Xue-Long Huang, Xiong-Feng Xu, Wei-Quan Xie, Su-Jun Zhang, Jian Tu. Oncol Lett 2018
8
50

Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
Zhonghong Wei, Yunlong Shan, Li Tao, Yuping Liu, Zhijie Zhu, Zhaoguo Liu, Yuanyuan Wu, Wenxing Chen, Aiyun Wang, Yin Lu. Mol Carcinog 2017
31
50


Anticancer effects of garlic and garlic-derived compounds for breast cancer control.
Airo Tsubura, Yen-Chang Lai, Maki Kuwata, Norihisa Uehara, Katsuhiko Yoshizawa. Anticancer Agents Med Chem 2011
72
50

The breast tumor microenvironment: role in cancer development, progression and response to therapy.
Suruchi Mittal, Nicola J Brown, Ingunn Holen. Expert Rev Mol Diagn 2018
36
50

Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells.
Yasamin Al-Qassab, Silvia Grassilli, Federica Brugnoli, Federica Vezzali, Silvano Capitani, Valeria Bertagnolo. BMC Cancer 2018
8
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.